| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 62.8353 | 66 |
| GSM780708 | Untreated after 4 days (C2_1) | 66.3754 | 68 |
| GSM780709 | Untreated after 4 days (C3_1) | 58.2789 | 63 |
| GSM780719 | Untreated after 4 days (C1_2) | 61.4065 | 65 |
| GSM780720 | Untreated after 4 days (C2_2) | 63.5324 | 66 |
| GSM780721 | Untreated after 4 days (C3_2) | 69.0938 | 69 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 64.4495 | 67 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 68.9612 | 69 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 76.3043 | 71 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 65.3804 | 67 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 57.9278 | 63 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 64.8414 | 67 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 58.7597 | 64 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 59.6663 | 64 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 53.2912 | 57 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 62.326 | 66 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 61.2788 | 65 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 57.2992 | 62 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 78.6513 | 71 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 62.5741 | 66 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 64.6972 | 67 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 69.4219 | 69 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 71.0287 | 69 |